About Syapse
Syapse is a Healthcare company based in San Francisco (United States) founded in 2008 by Tony Loeser, and was acquired by N-Power Medicine in January 2025. Developer of precision medicine for the treatment of cancer. Syapse has raised $221.1 million across 8 funding rounds from investors including Medidata, Intermountain Healthcare and General Electric. The company has 209 employees. Its chief executive, as recorded, is Ken Tarkoff. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is SYAPSE, INC. Its competitors include BostonGene, VieCure and Myka Labs; 2 of its 3 listed competitors have raised funding.
Company details
Syapse was founded in 2008 in San Francisco, United States, within the healthcare technology sector. A platform is provided by the company to enable molecular profiling and analysis of complex genomic data from cancer patients. Operations focus on precision medicine solutions that support clinical decision-making. Services are extended to healthcare providers and researchers across the United States, emphasizing data-driven oncology approaches.
- Headquarters San Francisco, United States
- Employees 209
- Founders Tony Loeser
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website syapse.com
- Social LinkedIn X Facebook
- Acquired by N-Power Medicine (Jan 2025)
- Legal Name Syapse, Inc.
- Total Equity Funding$221.1M (USD)
in 8 rounds
- Latest Funding Round$35M (USD), Series E
Jul 2022
- InvestorsMedidata
& 15 more
- Employee Count209
- Acquired byN-Power Medicine
(Jan 2025)
Funding Insights of Syapse
Syapse has successfully raised a total of $221.1M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $35 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $221.1M
- Total Rounds 8
- Last Round Series E — $35M
- First Round $3M
(Jan 2013)
- Investors Count 15
All 8 funding rounds of Syapse with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2022 | $35M | Series E | – | Innovatus Capital Partners | |
| Feb 2021 | $68M | Series E | – | Ally Bridge Group | |
| May 2020 | $30M | Series E | – | Revelation Partners | |
| May 2019 | $20.1M | Series D | – | – | – |
| Nov 2017 | $30M | Series D | – | Medidata, Amgen Business Development | |
| Jan 2016 | $25M | Series C | – | Ascension Ventures | |
| Jul 2014 | $10M | Series B | – | Safeguard Scientifics | |
| Jan 2013 | $3M | Series A | – | Social Capital | – |
16 investors in total: 16 institutional.
Investors in Syapse
Syapse has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include Medidata, Intermountain Healthcare and General Electric.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diversified debt funding is provided for growth capital opportunities. | innovatuscp.com | New York, United States | ||
Private equity and hedge fund investments in healthcare are managed. | ally-bridge.com | Hong Kong, China | ||
Corporate-backed venture capital is focused on the life science sector. | merckghifund.com | Kenilworth, United States | ||
Venture capital firm investing in life sciences & tech sectors | npv.vc | Cambridge, United States | ||
Venture capital firm investing in early and growth stage companies | 1953 | safeguard.com | Radnor, United States | |
US focused VC firm investing in seed & growth stage companies | 2011 | socialcapital.com | Menlo Park, United States | |
Venture capital firm investing in the healthcare sector | intermountainventures.com | Salt Lake City, United States | ||
Venture capital investments are facilitated by Amgen-backed entity. | amgenbd.com | Thousand Oaks, United States | ||
Ascension is recognized as a venture capital firm focused on early-stage tech investments. | ascension.vc | London, United Kingdom | ||
Corporate-backed venture capital firm focused on the healthcare sector | roche.com/venturefund.htm |
Investor details for Syapse
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Syapse
28 people are tracked at Syapse (6 in leadership, 13 in board & advisors, 9 in team); the tracked headcount is 209.
| Name | Role | Group |
|---|---|---|
Tony Loeser | Co-Founder & CTO | Leadership |
Ken Tarkoff | CEO | Leadership |
Joshua Loving | Associate Director, Clinical Data Science | Leadership |
Sheetal Walters | Sr. Director, Delivery & Strategic Programs | Leadership |
Daniel Brandt | Director Of Client Success - Sandbox Analytics | Leadership |
Monika Izano, PhD | Senior Director, Epidemiology And Analytics | Leadership |
Guillermo Garcia-Manero | Council Member | Board & advisors |
Benjamin Kummer | Council Member | Board & advisors |
Marcos De Lima | Council Member | Board & advisors |
Christopher Logothetis | Council Member | Board & advisors |
Charles Drescher | Council Member | Board & advisors |
Henry Kaplan | Council Member | Board & advisors |
Otis Brawley | Advisor | Board & advisors |
Nitin Baliga | Advisor | Board & advisors |
Vicente Valero | Council Member | Board & advisors |
Richard Schilsky | Advisor | Board & advisors |
George Simon | Council Member | Board & advisors |
Brian Parkin | Council Member | Board & advisors |
Mark Socinski | Council Member | Board & advisors |
Dana Hess, CTR | Clinical Abstractor Lead | Team |
8 more people are available in the full profile.
Complete people profiles for Syapse
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Syapse
4 dated milestones of Syapse across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Syapse is founded.
- Funding First funding round of $3.0M.
- Funding Latest funding round, Series E, of $35.0M.
- Exit Acquired by N-Power Medicine.
Competitors of Syapse
Syapse has 3 listed competitors in our database, 2 of them funded. They include BostonGene, VieCure and Myka Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bostongene.com | 2015 | Waltham, United States | $200M | 46 | Developer of cloud-based information and analytics platform to treat cancer | |
| viecure.com | 2015 | Greenwood Village, United States | $70M | 22 | Oncology treatment plans are generated via an AI-based platform. | |
| myka.bio | 2021 | San Francisco, United States | AI-based integrated solutions for interventional oncology procedures are provided. |
Detailed competitors of Syapse
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Syapse
Websites that share an audience with Syapse (syapse.com).
Websites whose visitors overlap most with Syapse. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| darkdaily.com | 100% | View details | |||
mlo-online.com | mlo-online.com | 91% | #1,376,773 | – | |
| ivantagehealth.com | 86% | View details | |||
cola.org | cola.org | 80% | #3,783,164 | – | |
| ascp.org | 79% | 281.2K | #94,411 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Syapse
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Syapse (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Syapse
Complete news archive for Syapse
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Syapse
Syapse was founded in 2008 and raised its 1st funding round 5 years after it was founded.
Syapse is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Ken Tarkoff is the CEO of Syapse, as recorded in our data.
Syapse is a funded company, having raised a total of $221.1M across 8 funding rounds to date. The company's 1st funding round was a Series A of $3M, raised on Jan 2013.
Syapse has 209 employees.
Syapse was founded in 2008 in San Francisco, United States, within the healthcare technology sector. A platform is provided by the company to enable molecular profiling and analysis of complex genomic data from cancer patients. Operations focus on precision medicine solutions that support clinical decision-making. Services are extended to healthcare providers and researchers across the United States, emphasizing data-driven oncology approaches.
Syapse's top competitors include BostonGene, VieCure and Myka Labs.
Syapse has 16 investors. Key investors include Medidata, Intermountain Healthcare, General Electric, Social Capital, and Revelation Partners.
Syapse operates through Syapse, Inc..
Yes. Syapse was acquired by N-Power Medicine in January 2025.